Abicipar pegol for treating wet age-related macular degeneration [ID1533]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Avacincaptad pegol for treating geographic atrophy caused by age-related macular degeneration [ID6401]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Digital technologies to support monitoring of vision change at home for people with age-related macular degeneration: early use assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 15 September 2026
Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Low-dose atropine eye drops for treating myopia in people 3 to 14 years [ID6517]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 3 September 2026
Monofocal intraocular lenses for cataract surgeryStatus:In developmentProgramme:Health technology evaluationExpected publication date: 10 March 2027
Polihexanide 0.8 mg/ml eye drops for treating acanthamoeba keratitis in people 12 years and over [ID6497]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC